Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Lung innate immune system imprinted by parenteral Bacillus Calmette–Guérin (BCG) immunization: role in anti-tuberculosis immunity

EF 2016-17

Résumé
Pulmonary tuberculosis (TB) is a disease of the lung and is now the leading cause of human disease and death worldwide. With an alarming rate of 1.8 million deaths and 9 million new cases of active disease annually, it has been estimated that 1/3rd of the world population is latently infected, making TB a major global health concern. In Canada, TB is especially a major concern among aboriginal communities, with the infection rates being 38 times in these communities than the rest of the nation. Lack of complete knowledge regarding the pathogenesis of TB has hindered the development of effective disease control strategies. Moreover, the emergence of antibiotic resistant TB is rapidly on the rise, suggesting an urgent need to develop more effective vaccination strategies. For more than 8 decades, parenteraly administered Bacillus Calmette–Guérin (BCG) vaccine has been globally used as the only approved vaccine against TB. Recently, it has also been observed that BCG vaccination provides protection against other infectious diseases unrelated to TB, and as a result reduces childhood mortality in many developing countries. The mechanisms underlying the heterologous effects of BCG vaccine remains unclear. In our laboratory, we are investigating the host immune responses following infection with TB. We also aim to investigate how the BCG vaccination enhances the immune system responses against TB and other unrelated infectious diseases. A better understanding of the immune responses that follow BCG vaccination will allow for the development of more effective vaccination strategies, ultimately decreasing the global burden of TB.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367379
Name
Vaseghi-Shanjani Maryam
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Lung innate immune system imprinted by parenteral Bacillus Calmette–Guérin (BCG) immunization: role in anti-tuberculosis immunity
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bacterial Infection; Bcg; Imprinted Immunity; Infectious Disease; Innate Immunity; Lung Disease; Trained Immunity; Tuberculosis; Vaccine
Abstract
Pulmonary tuberculosis (TB) is a disease of the lung and is now the leading cause of human disease and death worldwide. With an alarming rate of 1.8 million deaths and 9 million new cases of active disease annually, it has been estimated that 1/3rd of the world population is latently infected, making TB a major global health concern. In Canada, TB is especially a major concern among aboriginal communities, with the infection rates being 38 times in these communities than the rest of the nation. Lack of complete knowledge regarding the pathogenesis of TB has hindered the development of effective disease control strategies. Moreover, the emergence of antibiotic resistant TB is rapidly on the rise, suggesting an urgent need to develop more effective vaccination strategies. For more than 8 decades, parenteraly administered Bacillus Calmette–Guérin (BCG) vaccine has been globally used as the only approved vaccine against TB. Recently, it has also been observed that BCG vaccination provides protection against other infectious diseases unrelated to TB, and as a result reduces childhood mortality in many developing countries. The mechanisms underlying the heterologous effects of BCG vaccine remains unclear. In our laboratory, we are investigating the host immune responses following infection with TB. We also aim to investigate how the BCG vaccination enhances the immune system responses against TB and other unrelated infectious diseases. A better understanding of the immune responses that follow BCG vaccination will allow for the development of more effective vaccination strategies, ultimately decreasing the global burden of TB.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Vaseghi-Shanjani, Maryam
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~